THE ARMY, UNITED STATES DEPARTMENT OF
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1893-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://wrair-www.army.mil
Clinical Trials
87
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (69 trials with phase data)• Click on a phase to view related trials
Examining the Most Effective Method to Reduce Running Ground Contact Time
- Conditions
- Healthy Runners
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Keller Army Community Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06988709
- Locations
- 🇺🇸
Keller Army Community Hospital, West Point, New York, United States
Neurocognitive Ankle Training for Instability to Optimize Neuromusculoskeletal Outcomes (NATION)
- Conditions
- Chronic Ankle Instability
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Womack Army Medical Center
- Target Recruit Count
- 180
- Registration Number
- NCT06527287
Emovi 3D Knee Assessment Device Intervention for Operational Readiness
- Conditions
- Patellofemoral Pain SyndromePatellofemoral Pain
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Womack Army Medical Center
- Target Recruit Count
- 180
- Registration Number
- NCT06517056
- Locations
- 🇺🇸
Tripler Army Medical Center, Honolulu, Hawaii, United States
🇺🇸Womack Army Medical Center, Fort Liberty, North Carolina, United States
Dynamic Muscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction in Military Academy Cadets
- Conditions
- Anterior Cruciate Ligament Injuries
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Keller Army Community Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06341868
- Locations
- 🇺🇸
Keller Army Community Hospital, West Point, New York, United States
Weight Loss and Physical Fitness Following Pregnancy in Active Duty Women
- Conditions
- Weight LossPostpartum Weight Retention
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- Tripler Army Medical Center
- Target Recruit Count
- 74
- Registration Number
- NCT05518604
- Locations
- 🇺🇸
Tripler Army Medical Center, Honolulu, Hawaii, United States
🇺🇸Desmond Doss Health Clinic, Schofield Barracks, Hawaii, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 18
- Next
News
60 Degrees Pharmaceuticals Seeks FDA MUMS Designation for First Oral Canine Babesiosis Treatment
60 Degrees Pharmaceuticals will submit a Minor Use Minor Species (MUMS) designation request to the FDA for tafenoquine to treat acute canine babesiosis in 2025.
Nyrada's NYR-BI03 Shows Promise in Traumatic Brain Injury and Begins Phase 1 Clinical Trial
• Nyrada's lead drug candidate NYR-BI03 demonstrated statistically significant neuroprotection in a preclinical model of penetrating traumatic brain injury, according to a collaborative study with the Walter Reed Army Institute of Research. • The company has commenced recruitment for a Phase 1 clinical trial to assess safety, tolerability, and pharmacokinetics of NYR-BI03, with final readouts expected in Q3 2025. • Previous preclinical studies showed NYR-BI03 rescued 42% of brain tissue in stroke models and provided 86% cardioprotection following myocardial ischemic-reperfusion injury, positioning it as a promising first-in-class treatment.
Dx&Vx Advances Ferritin-Based Universal Coronavirus Vaccine to Phase 2 Trials Following Promising Phase 1 Results
Dx&Vx has acquired global development rights from Stanford University for a ferritin-based virus-like particle universal coronavirus vaccine that demonstrated neutralizing antibody levels more than ten times higher than mRNA vaccines in animal studies.